Today: 17 May 2026
Palantir stock tumbles to start 2026 — insider sale plan and Feb. 2 earnings date in focus (PLTR)
4 January 2026
1 min read

Palantir stock tumbles to start 2026 — insider sale plan and Feb. 2 earnings date in focus (PLTR)

NEW YORK, Jan 4, 2026, 09:31 ET — Market closed

  • Palantir shares fell 5.6% on Friday to close at $167.86.
  • An SEC filing showed a Palantir officer filed a Form 144 notice to sell up to 12,000 shares under a 10b5-1 plan.
  • Palantir is penciled in to report earnings on Feb. 2 by several market calendars, though the company has not confirmed a date.

Palantir Technologies’ shares fell 5.6% in the last regular session, closing at $167.86 on Friday.

A filing after the close showed a company officer filed a notice to sell stock, putting insider activity back in focus heading into Monday’s reopening.

The drop matters now because Palantir has been one of the market’s more closely watched AI-linked software names, and early-year positioning can amplify moves after a strong prior-year run. Commentary carried by Nasdaq.com pointed to profit-taking and a rotation out of software as the year opened.

Friday’s broader tape offered little help to high-growth software. The S&P 500 ended up 0.2% while the Nasdaq Composite was near flat, according to an Associated Press market wrap.

“Value is outperforming growth and AI infrastructure is up,” said Jed Ellerbroek, a portfolio manager at Argent Capital, describing the first session of 2026. Reuters

The Nasdaq.com commentary said there was no company-specific headline for Palantir on Friday, and pointed to broad weakness in software shares alongside strength in semiconductors as investors rotated within tech.

In the SEC filing, Ryan D. Taylor, listed as a company officer, filed a Form 144 — a notice that signals an intent to sell restricted or control shares and does not mean a sale has happened.

The filing indicated a proposed sale of up to 12,000 shares through Morgan Stanley Smith Barney and said the transactions were tied to a Rule 10b5-1 plan, a prearranged trading program that can allow executives to sell shares on a set schedule.

On the analyst front, Zacks Research upgraded Palantir to “strong buy” from “hold” in a report issued Thursday, according to MarketBeat. MarketBeat

For chart-focused traders, Friday’s intraday low around $166 has become a near-term reference point after the sharp drop.

But the downside scenario is straightforward: if rates keep rising and the market’s rotation away from high-multiple software persists, Palantir can stay under pressure even without new company headlines. Fresh insider-sale notices can also weigh on sentiment in a stock that has been volatile.

The next clear catalyst is Palantir’s quarterly results, which several calendars currently peg for Feb. 2, after market, though the company has not confirmed the date. Traders will also watch Monday’s reopen for signs the selloff is stabilizing.

Stock Market Today

  • Bipartisan Support for CLARITY Act Boosts Bitcoin and XRP in May
    May 16, 2026, 7:02 PM EDT. The CLARITY Act, which recently passed the Senate Banking Committee 15-9 with bipartisan support, sparked immediate gains in Bitcoin and XRP. Bitcoin surged to nearly $81,500, while XRP broke through $1.45 resistance briefly hitting $1.50. Historically, Bitcoin prices have rallied following significant regulatory milestones, including ETF approvals and government reserves, reaching highs of $126,000. XRP's performance is notably sensitive to regulatory clarity, exemplified by gains after an SEC ruling and classification as a digital commodity. If the CLARITY Act continues its momentum toward a Senate floor vote, both cryptocurrencies could experience further price appreciation by month-end, though Bitcoin and XRP are expected to move at different paces.

Latest articles

Joby Aviation Slides Monday With Air-Taxi in Focus

Joby Aviation Slides Monday With Air-Taxi in Focus

17 May 2026
Joby Aviation shares closed Friday at $10.36, down 2.6% for the day and 4.7% for the week. CEO JoeBen Bevirt-linked trusts sold over 421,000 shares under a preset 10b5-1 plan, filings showed. The stock traded between $10.04 and $10.58 during a volatile week. Broader markets and eVTOL sector peers also declined.
ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

17 May 2026
ImmunityBio closed at $7.97 Friday, down 2.2% after announcing exclusive U.S. rights to Japan BCG Laboratory’s Tokyo-172 strain for bladder cancer therapy. The Tokyo strain remains investigational in the U.S. and is not FDA-approved. Nasdaq was closed for the weekend; the next trading session is Monday. ImmunityBio’s Q1 product revenue rose to $44.2 million with $380.9 million in cash and securities.
Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

17 May 2026
Infleqtion Inc. shares fell 10.95% to $12.44 Friday, capping a rough week for quantum tech stocks. The company reported a first-quarter net loss of $30.3 million on $9.5 million in revenue, with 85% from government contracts. Infleqtion launched a new RF sensing platform and raised its 2026 revenue outlook, but warned of continued operating losses.
Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

17 May 2026
Synopsys shares fell 1.49% Friday to $502.42, ending the week down 2.72% amid a broad tech selloff and news that Coatue Management cut its stake by 54%. The Nasdaq Composite dropped 1.54% Friday, while the Philadelphia semiconductor index slid 4%. Synopsys will report fiscal Q2 results after the market closes on May 27. Wells Fargo and Citigroup raised their price targets for the stock earlier in the week.
ASX Ltd stock today: shares cling to the low end of the 52-week range as 2026 opens quietly
Previous Story

ASX Ltd stock today: shares cling to the low end of the 52-week range as 2026 opens quietly

Bank of America stock price today: BAC ends Friday up 1.7% as earnings, Fed loom
Next Story

Bank of America stock price today: BAC ends Friday up 1.7% as earnings, Fed loom

Go toTop